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Coronavirus disease 2019 (COVID-19),
caused by severe acute respiratory
syndrome coronavirus 2,
disproportionally affects adults (children
,5% in most reports).1 Adult critical
illness is characterized by acute
hypoxemia, multiorgan failure, and
high mortality.2,3 Reported risk
factors for severe illness include age,
cardiorespiratory comorbidities, obesity,
and laboratory findings (lymphopenia and
elevated D-dimer).2,4 Pediatric reports
describe low infection rates and
infrequent PICU admission.5,6 The
largest PICU report consists of 48
North American children.7 It describes
treatments and outcomes but not with
adequate granularity to understand
critical pediatric COVID-19. The Critical
Coronavirus and Kids Epidemiology Study
was designed to specifically investigate
severe cases and provide detailed data.
It involves .60 centers in nearly 20
countries from the Americas and Europe.
In this report, we provide preliminary
insights into our first 17 patients.
METHODS
The Critical Coronavirus and Kids
Epidemiology is a cohort study of
children ,19 years old with severe or
critical COVID-19. The study period
runs from April through December
2020. For this report, we included
patients enrolled through April 23.
We defined critical COVID-19 as
a positive severe acute respiratory
syndrome coronavirus 2 test result and
requiring ICU therapies (high-flow
nasal cannula [HFNC], noninvasive
ventilation [NIV], invasive mechanical
ventilation [IMV], vasoactive support,
continuous renal replacement therapy).
Severe COVID-19 included those
receiving mask or nasal oxygen
exceeding the pediatric acute
respiratory distress syndrome
(ARDS) “at risk” threshold.8
Deidentified data were collected by
using a modification of the
International Severe Acute Respiratory
and Emerging Infection Consortium
form (https://isaric.tghn.org/COVID-
19-CRF/). Local ethics approval was
obtained with a waiver of need for
consent.
RESULTS
We enrolled 17 children from 10 PICUs
in Chile, Colombia, Italy, Spain, and
the United States. Detailed data are in
the Supplemental Information. Most
patients were male (65%), young
(median 4 years; range 0.08–18 years),
and without known COVID-19 exposure
(14 of 17). Comorbidities (Table 1,
Supplemental Table 3) were common
(71%) but variable. Symptoms were
heterogenous, with fever and cough
being most frequent (Table 1,
Supplemental Table 3). Most with
gastrointestinal (GI) symptoms (4 of 6)
were also diagnosed with myocarditis
(Supplemental Table 4). All these were
from Europe and without previous
cardiovascular disease.
Patients had frequent laboratory
testing (Table 1, Supplemental Table 5).
Common findings included
leukocytosis, lymphopenia, elevated
inflammatory markers, D-dimer, and
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